Shenzhen YHLO Biotech (SHA:688575) received the medical device registration certificate for its aldosterone assay kit.
The kit is used for determining the aldosterone hormone in human serum, plasma and urine samples, according to a Nov. 30 filing with the Shanghai bourse.
Shares of the biotechnology company closed 1% higher Monday.